JFIFC    $ &%# #"(-90(*6+"#2D26;=@@@&0FKE>J9?@=C  =)#)==================================================" }!1AQa"q2#BR$3br %&'()*456789:CDEFGHIJSTUVWXYZcdefghijstuvwxyz w!1AQaq"2B #3Rbr $4%&'()*56789:CDEFGHIJSTUVWXYZcdefghijstuvwxyz ?QHJJX E^*D^ԪSi9bS@NNUm?m.ߘSJF*L}:RcځRmcP2"(~ߥ}HG҂>Ґ!+JL)_j )^ixz(jFZ𢜫ER*( 銑SJN{T7W٨24,0Q\.K{ ˔1цx+\tkgxIƅz*c&Ǥ;n+>"iןs.8볆X"Y!ttar h~aҫ^Gd2GJu6)IO?tTߺ0ͺmg?*.~]IDHɨ\حZӯ,zGNxPL-NO5[A|~Y8W5Mn-;2* *̤E;c 3\u^\'T\q DK/0oxOaQK{e\y>fUEv`Ey8\f#6 Ydm'qӵ{ l3Es Æ3)xJGҀ!+ yEJښ}($ئsax]6lZ)Nv͸5Mƶ)m&yɮcRl",1olQ|c3ҵ:d O(4TyM*uFъMCW{,TجGLH62()SGIe8eޠҹK>&1t^X@FƉb՝?%g\LhX/$]=vQ8?k\r #ч2" J@LeZԊW]Lg+/Y6G2TM]<:MkwRGc[4MvB/v=f$n scqѢH>D($n)^\!أҨ͖9>JtF=;ɕc9@FLcq2R/ 6@OX69ۚ-0 AI ɑn03QUk6ols 1NZ%*0تSKD6O&lIr`^%F*\sJHU=k/#ꡗ*q]'_ZEY=oʦӯaTeKH+J9?$h7pGUKf&y_p3"bw&0)Λ8"F=*O׶=IO:f ;M_b+F:KKp.>0+gUEWx{ڏEnRkf90ʃ{U{6ٵEĂ,aOu#c%UtL#gd FM<ס!IIlk2*jq5_jXVXZJ+T#}Gr EUεF$fS$_.9WO_(~ ?OSi QJqEY\MAa]:k8 @8iI] 9 U-ykK.j0O d{ӚhoOT;NxzQ}QxSƚͻt,B zIhLdV쯥¥>vE:>d^kv~ڪ G{LaE`nxc:Vbp#\u(4qGv,a֮=4%Z,QhvZ{rOSPZaf"&x\ՙY!cG\čMfBXx^d4 @cGWٙrKu5*|">Ae~Bi'$)nWg5DizN.Wmm~+%JĎRUFN.{I}jn&C: 9&6e ޺˥y2&iHM.|aE?W2[ J8G We!xӕՙˏ^yF8ZLȱ85i4-,#P=OĚ~B>6ۙ D︆{L,Jh-$tZ.x#Yo۷""~+ѭ|Qj)42 yR>\҈<[ 4(LFD+zu-S_6 #CMAxd5iV$*(ZIka{7 ¹T[w\ڱp}ҊP>nUqS/CڧSgJ\;HrwXv۾N>kq,7;6p?=5:2&9C\̼cϖ +So}"GreƼ?AL2s#^\4&0(׎ѨXB}NEO>gM4=`BV#3ZW1A GdQ/ hX3/c";Ect4D:|` Nzu+Rw2j"tqW!+q<ů## MrzF/͂AuR-i{,RTkn—o/4z`qMmH}Q|1Rm_.vnN]|V6j.{E6"RqpIy=٫+R>c,?|UmmR>5-flvqU'oH0@)TTmVd }0I]J^εXSO?JtjucxɓNmO?-՝s]?՞q⽄>#/]*#5}nIjOG1[Gr|t뱵д/>wч́`W[}ՔlA$sP+d`:+=7Q$έzsI=)Acҥ 5=jd `1\Uݺ]Y UpXuO?G?e7$֪M7B'E6Z%6I x-؏ ٢iT?klUxoux4i sɤ4cs"5aҟ ^}PE} 浴,m`S;jO 54{ Q㿊|k/_z}^mʩ޺Qiz=( yt~D}Nepy}J\X$ Bmlſ*n: ǥr^0]n  TԧYUpx![-B)@'i J4HK08*ODv*:O08=\[wT~T:ۃT'MH#8'{*h@=׮ m\.α]p#К)_!{2dԀNJt"Gd[ 2Y1 5.JcҴ>k#5S3ޮh3b Voر$R0t=N]ҰA:W]Mecpƚ4p/P^#ϟLQB/M'aڜF`&ʰ$ޯ'vf#Ҥ͂k^f#1Ĥ>FsXzZ&9[bm+^y zdWLcT|ʣ99RA?_< FT]:OEm s+ڣ0{c%,8Y$HaF*;q\+"b3GR Qrj8杍WMܬpx>w$W?/ע)f;k .#<苃 ]6)EuJ@:|q>AdBZ FcX*ްA+ׂ؛?tMs+4u#ӡ~%*8j MF0B$ƑX|cEAQp ʦIzO EdM<`pg'Be}ĎE2)"b7b6Y4t"OxTHIQ<'sG FJ.`ve& ?J%>v9nfm=ˆ@wN=LJ|-gz0cJP_(K^~t?Nybx_Or)U#sH3a޷| 0tI#Eu70v=:uԭmP()JweF ^i>bWq;K1mI(n6},:)+c!!R8uInn" uKy$"F@H#޸CE mcZVVѝ-eqip9Zv0#4g*?q#ҊwMK⚥x:2crn3*E=sN3K3g)V{*cFpTy=aWe0O1f@==I{ekXĞrlwm8֩h+\MgJHIEwѭva8;n\\b.VM[`u5oEhxC(AqVͽXK#r#؊#=k^Yxݴi.Dc@qO5Z\Jb.0IW;Խ-.U$Tݝ]byP$ mX"RO[ CM¡G;N3ҕX u)UX. U@x&^siָUaNH-ZI5(E+z$ÁZ:?k9'G9܄dUUKMTl VR1\]KORaQnw3/lרp<^dXhv+U*f4; g 敮>0^B`R7rn=LV+8#h csާCLe)p6p>(0~VNLdK 9>f͍?)ԫ1c/HgV2 8ՔW%@ VLcM 3i=@'j'8"7GV[9lDOSUsǥG"Wć֚PzrOi'g͡Ebn52+x?DdHq $ $*E5,H44|`JcUO~]^pZ)i jJe/c~"+rHrS 7*T2qԄ. Again, no adverse side affects. Creatine does have one well-documented side effect. It causes an increase in muscle mass. When taken as prescribed it has the capacity to increase body weight by as much as seven pounds in five days.<br>Are there any long term effects? The long term effect of creatine has never been studied. However, creatine has been used in the past and without incident. Athletes in the 1940s and 1950s used it until steroids became available. They switched to steroids because they got results much faster. The Eskimos ingest up to four grams of creatine per day through their high consumption of meat and fish, twice that of Americans, and, have not had any documented ill effects.<br>How much time is considered long term? Is it 5 years, 10 years, or 50 years? The FDA has been studying creatine since it exploded onto the sports scene in 1992. Dr. Mike Stone from Appalachian State University, a leader in the field of Muscle Physiology, has been studying athletes who have been taking creatine for as long as six years. To date, there are no reports of kidney, heart or liver problems.<br>Since there is no docmented evidence that creatine is a health hazard, the benefits of accelerated muscle development using creatine, far outweigh at least one alternative - using anabolic steroids. For those concerned about sending the wrong message to young adults, consider this; it is a great service to young people to let them know there is a viable alternative to using anabolic steroids.<br><br>_______________________________________<br><br>Creatine is criticized <br>for the following<br><br>1. It could have been a cause in the death of three college wrestlers who died trying to  make weight. <br><br>2. It caused muscle cramping due to water retention and dehydration.<br><br>3. Creatine has an adverse effect on liver and kidney function.<br><br>4. It is lacking in long term research.<br><br>5. To a lesser degree of concern, creatine causes stomach upset, diarrhea and nausea.<br><br><br><br>raining. Strength Conditioning, 17: 28-32.<br><br>Faigenbaum, A. (2002). Resistance training for adolescent athletes. Athletic Therapy Today. 7(6): 30-35.<br><br>Faigenbaum, A. (2001). Strength training and children s health. Journal of Physical Education, Recreation and Dance, 72: 24-30.<br><br>Faigenbaum, A. (2000). Strength training for children and adolescents. Clinics in Sports Medicine, 19: 593-619.<br><br>Faigenbaum, A., et al. (2001). Effects of different resistance training protocols on upper body strength and endurance development in children. Journal of Strength and Conditioning Research, 15(4): 459-465.<br><br>Faigenbaum, A., & Chu, D. (2001, December). Plyometric training for children and adolescents. ACSM Current Comment.<br><br>Faigenbaum, A., Kraemer, W., Cahill, B., et al. (1996). Youth resistance training: position statement paper and literature review. Strength & Conditioning, 18: 62-75.<br><br>Faigenbaum, A., LaRosa Loud, R., O Connell, J., et al. (2001). Effects of different resistance training protocols on upper body strength and endurance development in children. Journal of Strength and Conditioning Research, 15(4): 459-465.<br><br>Faigenbaum, A., Micheli, L. (2000). Preseason conditioning for the preadolescent athlete. Pediatric Annals, 29: 156-161.<br><br>Faigenbaum, A., Milliken, L., LaRosa Loud, R., Burak, B., Doherty, C., & Westcott, W. (2002). Comparison of 1 and 2 days per week of strength training in children. Research Quarterly fl2buGV":OnH&BX1 U͞3&2ysFoiZ ~ /f$$1xv%5fy1\ͳw-'thݎ$|l~ī_5+de6N&] b`_ے9u9|W=sJ Nr7'aS6v@nD{Pkm2N~dOV9CN#Zw9{%eGA`T}d;Is!g.cTP<vTӐ v#@v D$ v;p@: ٍV@4 P5j7v/uf JbDSVrMqKoC8#A6[fv߭~ 4ȭ)Ðpom`ڪW| u,b3SӦ:Y-{a>{phL#-$\ % >qjk)?ˇj՚bx/dn$,IcRے|s#1V/G⬧lcT8j QkxbiN1JW R i_ɌWHei\֝3*zuΏ(=&1}rYC Ӎ<{֞; 0mX"KS` jyze4$?>C_KT+zP ;qPT֔\0Ҟb } m$1]HtU&ᅵ6(Vf; y:@4aZGS®vEN<Mh;YI1Kמ<$Vn)[Tփ;bJnǮ;kvvORce4?A娓稓13ת٪